Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AIDS With Tuberculosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01687504
What this trial is testing

Pharmacokinetics of Anti-TB Drugs in HIV/TB Co-infected Children in Ghana

Who this might be right for
TuberculosisHIV
The Miriam Hospital 106
Post-approval studies (Phase 4)Study completedNCT00107887
What this trial is testing

TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy)

Who this might be right for
TuberculosisHIV Infections
Johns Hopkins University 17,415
Testing effectiveness (Phase 2)Looking for participantsNCT05590455
What this trial is testing

Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis

Who this might be right for
Tuberculous MeningitisHIV I Infection
ANRS, Emerging Infectious Diseases 130
Post-approval studies (Phase 4)Study completedNCT00617643
What this trial is testing

Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis

Who this might be right for
HIV InfectionsTuberculosis
Makerere University 18
Testing effectiveness (Phase 2)Study completedNCT01138202
What this trial is testing

Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy

Who this might be right for
HIV InfectionsTuberculosis
The HIV Netherlands Australia Thailand Research Collaboration 40
Large-scale testing (Phase 3)Study completedNCT00130247
What this trial is testing

Tuberculosis Treatment Shortening Trial

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 394
Post-approval studies (Phase 4)UnknownNCT01875952
What this trial is testing

Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL)

Who this might be right for
Human Immunodeficiency Virus (HIV)Tuberculosis (TB)Latent Tuberculosis Infection (LTI)
Instituto Nacional de Salud Publica, Mexico 100
Not applicableNot Yet RecruitingNCT07278453
What this trial is testing

TB SCReening Improves Preventive Therapy Uptake in Pregnant Women With HIV

Who this might be right for
Pregnant HIV Positive WomenHIVTuberculosis (TB)
University of California, San Francisco 1,500
Testing effectiveness (Phase 2)Study completedNCT02391415
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of VPM1002 in Comparison With BCG in HIV-exposed/-Unexposed Newborn Infants in South Africa

Who this might be right for
Tuberculosis
Serum Institute of India Pvt. Ltd. 416
Testing effectiveness (Phase 2)Study completedNCT03819114
What this trial is testing

Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy

Who this might be right for
HIV InfectionsTuberculosis
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 122
Not applicableStudy completedNCT04926922
What this trial is testing

PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia

Who this might be right for
TuberculosisHIV
National Institute of Allergy and Infectious Diseases (NIAID) 200
Not applicableActive Not RecruitingNCT05342064
What this trial is testing

Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service

Who this might be right for
TuberculosisHIV CoinfectionTuberculosis Infection
Baylor College of Medicine 6,500
Testing effectiveness (Phase 2)Study completedNCT01751568
What this trial is testing

Safety, Tolerance and Pharmacokinetics of Raltegravir-Containing Antiretroviral Therapy in Infants, Children Infected With HIV and TB

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 40
Not applicableUnknownNCT03478033
What this trial is testing

Rifampicin vs Rifabutin in HIV/AIDS Patients Combined With Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryAIDS
Shanghai Public Health Clinical Center 230
Large-scale testing (Phase 3)Looking for participantsNCT06497465
What this trial is testing

Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment

Who this might be right for
TuberculosisHIV
Johns Hopkins University 150
Large-scale testing (Phase 3)Study completedNCT01404312
What this trial is testing

Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)

Who this might be right for
TuberculosisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 3,000
Large-scale testing (Phase 3)Study completedNCT03915366
What this trial is testing

Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia

Who this might be right for
PneumoniaHIV/AIDSTuberculosis+1 more
Hospital Universitario 12 de Octubre 563
Not applicableStudy completedNCT00463086
What this trial is testing

Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons

Who this might be right for
TuberculosisLatent Tuberculosis InfectionHIV Infections
University of Cape Town 1,368
Large-scale testing (Phase 3)Study completedNCT04738812
What this trial is testing

Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression

Who this might be right for
TuberculosisHIV-1-infectionImmuno-Deficiency
ANRS, Emerging Infectious Diseases 1,330
Early research (Phase 1)Study completedNCT02013245
What this trial is testing

Dose-Escalation Study to Evaluate the Safety and Immunogenicity of MTBVAC Vaccine in Comparison With BCG Vaccine.

Who this might be right for
TuberculosisHealthy
Biofabri, S.L 36
Next Page